SCHEMBL4352016

SCHEMBL4352016

CCCn1c(=O)c(-c2cccs2)cc2c(C)nc(Nc3ccc(N4CCN(CC)CC4)cc3)nc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WEE1 P30291 1/20 0.44
PAK1 Q13153 3/20 0.42
PAK3 O75914 2/20 0.42
PAK2 Q13177 2/20 0.42
PKN1 Q16512 2/20 0.42
PAK4 O96013 1/20 0.42
PTK2 Q05397 8/20 0.41
CDK4 P11802 4/20 0.41
CCND1 P24385 3/20 0.41
CCND3 P30281 2/20 0.41
CCND2 P30279 1/20 0.41
FLT3 P36888 1/20 0.41
SRC P12931 2/20 0.40
MAP3K7 O43318 1/20 0.40
FGFR1 P11362 1/20 0.40
CDK6 Q00534 3/20 0.40
CDK2 P24941 2/20 0.40
CDK9 P50750 2/20 0.40
CCNT1 O60563 1/20 0.40
CCNE1 P24864 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188946 0.94 WEE1 (0.47) WEE1PAK1PAK3PAK2PKN1
SCHEMBL189156 0.90 WEE1 (0.54) WEE1PAK1PAK3PAK2PKN1
SCHEMBL189076 0.87 CDK4 (0.42) WEE1PTK2CDK4CCND1CCND3
SCHEMBL4342360 0.87 PTK2 (0.48) WEE1PAK1PKN1PAK4PTK2
SCHEMBL189185 0.87 WEE1 (0.46) WEE1PAK1PAK3PAK2PKN1
SCHEMBL14306579 0.85 CDK4 (0.46) WEE1PAK1PAK3PAK2PKN1
SCHEMBL4355205 0.83 KDM4E (0.50) WEE1PAK1PKN1PAK4CDK4
SCHEMBL12095760 0.82 CDK4 (0.42) WEE1PAK1PKN1PAK4CDK4
SCHEMBL4216668 0.81 WEE1 (0.47) WEE1PAK1PAK3PAK2PKN1
SCHEMBL188843 0.81 PTK2 (0.50) WEE1PAK1PKN1PAK4PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2056829-A2 USING PI3K AND MEK MODULATORS IN TREATMENTS OF CANCER Exelixis, Inc. (US) 2009-05-13 EP claimed
EP-1931670-A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3K Exelixis, Inc. (US) 2008-06-18 EP claimed
WO-2008021389-A2 USING PI3K AND MEK MODULATORS IN TREATMENTS OF CANCER EXELIXIS, INC. (US) 2008-02-21 WO claimed
WO-2007044698-A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα EXELIXIS, INC. (US) 2007-04-19 WO claimed